Maninder Hora's Net Worth
$7.21 Million
Who is Maninder Hora?
Maninder Hora has an estimated net worth of $7.21 Million. This is based on reported shares across multiple companies, which include FACET BIOTECH CORP, NEKTAR THERAPEUTICS, and PDL BIOPHARMA, INC..
SEC CIK
Maninder Hora's CIK is 0001443159
Past Insider Trading and Trends
2017 was Maninder Hora's most active year for acquiring shares with 8 total transactions. Maninder Hora's most active month to acquire stocks was the month of November. 2017 was Maninder Hora's most active year for disposing of shares, totalling 12 transactions. Maninder Hora's most active month to dispose stocks was the month of March. 2017 saw Maninder Hora paying a total of $2,786,700.00 for 315,000 shares, this is the most they've acquired in one year. In 2017 Maninder Hora cashed out on 433,707 shares for a total of $5,056,537.17, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FACET BIOTECH CORP No price found
VP, Prod Ops. & QualityManinder Hora used to own units in Common Stock but no longer holds any shares there.acquired a total of 18,731 shares in FACET BIOTECH CORP, Maninder also disposed a total of 21,811 shares of FACET BIOTECH CORP equalling to $579,686.76.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.80K |
$27.00 | -$372,681.00 |
0
|
Apr 21
| |||
Form 4
| -35.25% | -7.52K |
$27.00 | -$202,932.00 | 13.8K |
Apr 20
| |||
Form 4
| +39.17% | 5.33K |
—
|
—
| 18.92K |
Aug 6
| |||
Form 4
| -3.49% | -492.00 |
$8.28 | -$4,073.76 | 13.6K |
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
| +1,968.58% | 13.41K |
—
|
—
| 14.09K |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEKTAR THERAPEUTICS (NKTR) Snapshot price: $1.12
SVP Pharma Dev & Mfg OpsManinder Hora owns 94,694 units of Common Stock which is worth $106,057.28. In the year 2012 Maninder Hora acquired a total of 348,833 shares in NEKTAR THERAPEUTICS at a cost of $3,003,000.44, Maninder also disposed a total of 282,874 shares of NEKTAR THERAPEUTICS equalling to $9,528,067.78.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.52% | -2.45K |
$31.37 | -$76,825.13 | 94.69K |
May 16
| |||
Form 4
| -2.40% | -2.39K |
$42.39 | -$101,142.54 | 97.14K |
Feb 19
| |||
Form 4
| +22.83% | 18.5K |
—
|
—
| 99.53K |
Dec 14
| |||
Form 4
| -5.48% | -4.69K |
$38.25 | -$179,545.50 | 81.03K |
Nov 16
| |||
Form 4
| +11.81% | 9.05K |
$58.40 | -$347,246.40 | 85.72K |
Aug 15 - Aug 16
| |||
Form 4
| -5.06% | -4.06K |
$83.39 | -$338,563.40 | 76.2K |
May 16
| |||
Form 4
|
—
|
0
|
$56.44 | -$49,426.92 | 80.26K |
Scheduled
|
Apr 10
| ||
Form 4
|
—
|
0
|
$55.01 | -$2,820,084.32 | 80.26K |
Scheduled
|
Apr 5 - Apr 9
| ||
Form 4
| -3.46% | -2.88K |
$82.94 | -$238,452.50 | 80.26K |
Feb 16
| |||
Form 4
| +22.01% | 15K |
—
|
—
| 83.14K |
Dec 15
| |||
Form 4
| +16.15% | 9.4K |
$44.23 | -$247,555.31 | 67.64K |
Nov 15 - Nov 16
| |||
Form 4
|
—
|
0
|
$18.05 | -$329,968.46 | 58.23K |
Scheduled
|
Nov 6 - Nov 7
| ||
Form 4
|
—
|
0
|
$17.85 | -$108,512.73 | 58.23K |
Scheduled
|
Oct 5
| ||
Form 4
| -4.83% | -2.96K |
$19.32 | -$57,109.92 | 58.23K |
Aug 16
| |||
Form 4
| -4.65% | -2.96K |
$19.55 | -$57,848.45 | 60.69K |
May 16
| |||
Form 4
|
—
|
0
|
$17.70 | -$1,440,000.00 | 63.65K |
Scheduled
|
Apr 5
| ||
Form 4
| -3.33% | -2.19K |
$13.14 | -$28,842.30 | 63.65K |
Feb 16
| |||
Form 4
| +29.50% | 15K |
—
|
—
| 65.84K |
Dec 13
| |||
Form 4
| -3.18% | -1.65K |
$13.96 | -$23,089.84 | 50.34K |
Nov 16
| |||
Form 4
| -5.98% | -3.31K |
$17.56 | -$58,035.80 | 52K |
Aug 16
| |||
Form 4
| +386.04% | 26K |
—
|
—
| 32.73K |
Jul 14
| |||
Form 4
| +22.95% | 1.33K |
$13.58 | -$11,339.08 | 7.13K |
May 16 - May 17
| |||
Form 4
| +26.15% | 1.2K |
$11.92 | -$11,478.74 | 5.8K |
Feb 16 - Feb 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDL BIOPHARMA, INC. No price found
VP Product Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||